Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
Pre-Market: 20:00
Charles River Laboratories International Net Income (Quarterly) : -0.76M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.76M |
| March 31, 2026 | -14.80M |
| December 31, 2025 | -276.29M |
| September 30, 2025 | 55.56M |
| June 30, 2025 | 52.69M |
| March 31, 2025 | 25.88M |
| December 31, 2024 | -213.75M |
| September 30, 2024 | 70.30M |
| June 30, 2024 | 94.26M |
| March 31, 2024 | 74.48M |
| December 31, 2023 | 188.95M |
| September 30, 2023 | 88.02M |
| June 30, 2023 | 99.44M |
| March 31, 2023 | 103.95M |
| December 31, 2022 | 189.11M |
| September 30, 2022 | 97.61M |
| June 30, 2022 | 110.66M |
| March 31, 2022 | 95.23M |
| December 31, 2021 | 139.83M |
| September 30, 2021 | 105.16M |
| June 30, 2021 | 89.92M |
| March 31, 2021 | 63.94M |
| December 31, 2020 | 144.19M |
| September 30, 2020 | 102.61M |
| June 30, 2020 | 67.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.84M |
| December 31, 2019 | 80.51M |
| September 30, 2019 | 73.55M |
| June 30, 2019 | 44.31M |
| March 31, 2019 | 55.69M |
| December 31, 2018 | 60.20M |
| September 30, 2018 | 60.90M |
| June 30, 2018 | 52.85M |
| March 31, 2018 | 53.27M |
| December 31, 2017 | -29.04M |
| September 30, 2017 | 52.99M |
| June 30, 2017 | 54.67M |
| March 31, 2017 | 46.96M |
| December 31, 2016 | 45.28M |
| September 30, 2016 | 37.69M |
| June 30, 2016 | 35.54M |
| March 31, 2016 | 37.58M |
| December 31, 2015 | 33.26M |
| September 30, 2015 | 37.90M |
| June 30, 2015 | 49.25M |
| March 31, 2015 | 31.62M |
| December 31, 2014 | 28.54M |
| September 30, 2014 | 32.30M |
| June 30, 2014 | 36.46M |
| March 31, 2014 | 32.63M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 258.00M |
| Medpace Holdings, Inc. | 121.36M |
| Fortrea Holdings, Inc. | -13.20M |
| Avantor, Inc. | 38.10M |
| Champions Oncology, Inc. | -0.667M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.004B |
| Total Expenses (Quarterly) | 1.006B |
| EPS Diluted (Quarterly) | -0.0309 |
| Enterprise Value | 17.12B |
| Gross Profit Margin (Quarterly) | 36.29% |
| Profit Margin (Quarterly) | -0.08% |
| Earnings Yield | -1.63% |
| Operating Earnings Yield | 3.70% |
| Normalized Earnings Yield | 0.6301 |